scholarly journals Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report

2019 ◽  
Vol 7 (7) ◽  
pp. 1419-1421 ◽  
Author(s):  
Ryosuke Nakahara ◽  
Takahiro Sumimoto ◽  
Masao Ogata ◽  
Yuhki Sato ◽  
Hiroki Itoh
Keyword(s):  
Case Report ◽  
Chronic Myeloid Leukemia ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Myeloid Leukemia ◽  
Hepatic Dysfunction ◽  
Therapeutic Drug

scholarly journals Successful determination of imatinib dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction.

2021 ◽  
Author(s):  
Ryosuke Nakahara ◽  
Takahiro Sumimoto ◽  
Ryota Tanaka ◽  
Masao Ogata ◽  
Hiroki Itoh
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Therapeutic Drug Monitoring ◽  
Renal Dysfunction ◽  
Drug Monitoring ◽  
Myeloid Leukemia ◽  
Therapeutic Drug ◽  
First Line ◽  
Acute Renal Dysfunction ◽  
First Line Treatment

Imatinib is used as first-line treatment for chronic myeloid leukemia (CML) even in patients with impaired renal function. We successfully used therapeutic drug monitoring to determine the dose for re-administration of imatinib in a CML patient who initiated dialysis for acute renal dysfunction associated with the initial imatinib therapy.

scholarly journals Role of Therapeutic Drug Monitoring and Challenges in the Management of Infantile Chronic Myeloid Leukemia

2021 ◽  
Vol 18 (2) ◽  
Author(s):  
Sneha Tandon ◽  
Raviraj Deshpande ◽  
Gaurav Narula ◽  
Maya Prasad ◽  
Amey Paradkar ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Myeloid Leukemia ◽  
Therapeutic Drug

Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory

2012 ◽  
Vol 27 (6) ◽  
pp. 690-697 ◽  
Author(s):  
Stéphane Bouchet ◽  
Karine Titier ◽  
Nicholas Moore ◽  
Régis Lassalle ◽  
Basmah Ambrosino ◽  
...  
Keyword(s):  
Chronic Myeloid Leukemia ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Myeloid Leukemia ◽  
Therapeutic Drug

Utility of Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis

2019 ◽  
Vol 41 (12) ◽  
pp. 2558-2570.e7 ◽  
Author(s):  
Manuel García-Ferrer ◽  
Aneta Wojnicz ◽  
Gina Mejía ◽  
Dora Koller ◽  
Pablo Zubiaur ◽  
...  
Keyword(s):  
Systematic Review ◽  
Chronic Myeloid Leukemia ◽  
Therapeutic Drug Monitoring ◽  
Drug Monitoring ◽  
Myeloid Leukemia ◽  
Meta Analysis ◽  
Therapeutic Drug
Sign in / Sign up

Export Citation Format

Share Document